Abstract
- Mycobacterium abscessus is a multidrug-resistant nontuberculous mycobacterium capable of causing otomastoiditis and its treatment is complex with frequent adverse events. - Ten children (mean age: 8 years old; 70% males) were treated according to our institutional protocol. - Patients within one-year post-treatment reported a decreased QoL, with GCBI and COMBI scores of -12.91 and 10.94. - In contrast, patients evaluated more than one year after finishing treatment reported an improved QoL by both the GCBI (difference (Δ) = 23.9 points; p > 0.05) and COMBI (Δ = 19.4 points; p = 0.00). - The disease-induced hearing loss is reduced with successful treatment.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
